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ABSTRACT
Objectives: According to a large-scale international
survey, Peru has one of the highest prevalences of
asthma worldwide; however, data from this survey
were limited to participants from urban Lima. The
authors sought to characterise the epidemiology of
asthma in Peru in two regions with disparate degrees
of urbanisation. In this manuscript, the authors
summarise the study design and implementation.
Design: A cross-sectional study.
Participants: Using census data of 13e15-year-old
adolescents from two communities in Peru, the
authors invited a random sample of participants in
Lima (n¼725) and all adolescents in Tumbes (n¼716)
to participate in our study.
Primary and secondary outcome measures: The
authors asked participants to complete a questionnaire
on asthma symptoms, environmental exposures and
socio-demographics and to undergo spirometry before
and after bronchodilator, skin allergy testing and
exhaled nitric oxide testing. The authors obtained
blood samples for haematocrit, total IgE levels, vitamin
D levels and DNA in all participants and measured
indoor particulate matter concentrations for 48 h in
a random subset of 70e100 households at each site.
Results: Of 1851 eligible participants, 1441 (78%)
were enrolled and 1159 (80% of enrolled) completed
all physical tests. 1283 (89%) performed spirometry
according to standard guidelines, of which 86% of
prebronchodilator tests and 92% of
postbronchodilator tests were acceptable and
reproducible. 92% of allergy skin tests had an
adequate negative control. The authors collected blood
from 1146 participants (79%) and saliva samples from
148 participants (9%). Overall amounts of DNA
obtained from blood or saliva were 25.8 mg, with
a 260/280 ratio of 1.86.
Conclusions: This study will contribute to the
characterisation of a variety of risk factors for asthma,
including urbanisation, total IgE levels, vitamin D levels
and candidate genes, in a resource-poor setting. The
authors present data to support high quality of survey,
allergic, spirometric and genetic data collected in our
study.
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ARTICLE SUMMARY
Article focus
- We sought to characterise the epidemiology of
asthma in Peru by studying two regions with
disparate degrees of urbanisation.
- We summarise the study design, implementation
and standard operating procedures and provide
quality control data for important outcome and
exposure variables.
Key messages
- We present data to support high quality of
survey, allergic, spirometric and genetic data
collected in our study.
Strengths and limitations of this study
- This study will contribute to the characterisation
of a variety of risk factors for asthma, including
urbanisation, total IgE levels, vitamin D levels
and candidate genes, in a resource-poor setting.
- This study is cross-sectional and therefore does
not track symptoms over time to directly
determine causality. In addition, we did not
collect stool samples to assess parasitic infec-
tions nor do we have information on respiratory
infections in early childhood.
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Open Access ResearchINTRODUCTION
As poorer countries undergo rapid urbanisation and
development, rates of asthma have increased. These
increases have been reported across continents.
1 It has
become clear that asthma is no longer a developed
country disease. Worldwide, it is reported that the prev-
alence of asthma is approximately 300 million.
2 Asthma
is currently the 25th leading cause of disability-adjusted
life-years lost, and its burden is comparable to that of
diabetes mellitus. In comparative studies, asthma rates
have been higher in urban areas than in rural areas,
34with
reasons for this varying from outdoor air pollution
56to
the ‘hygiene hypothesis.’
7
However, limited research on asthma in Peru has been
published. A MEDLINE search of ‘ASTHMA’ and
‘PERU’ revealed only 16 published articles. According to
the questionnaire from the International Study of
Asthma and Allergies in Childhood (ISAAC), 48% of
children in Peru reported lifetime wheeze and 26%
reported wheezing in the last year. A Peru-based study
reported that 23% of children in a Lima shanty-town
showed decreases in forced expiratory volume in one
second (FEV1)o f>15% following exercise testing.
8 Both
these studies, however, were limited to urban Lima.
Other studies in Peru have shown elevated rates of
diagnosis with more trafﬁc ﬂow,
6 sought to validate
exercise challenge as a diagnostic method at high alti-
tude
9 and shown elevated nitrite levels in sputum of
patients with asthma.
10
Other developing counties with rapid urbanisation
have equally high rates of asthma. For example, in
Kenya, researchers found that exercise-induced bron-
choconstriction increased from 13% to 23% in a rural
versus an urban setting.
11 Another group found that in
Ethiopia, the odds of asthma was 3 to 1 in an urban
versus a rural setting.
4
A number of studies in developed countries have
linked asthma to allergies in the form of eczema allergic
rhinitis and elevated circulating IgE.
12e15 The ISAAC
study showed high levels of allergic rhinitis and eczema
in populations that also had high levels of wheezing.
Environmental exposures have also been connected to
asthma risk or severity, particularly exposure to particu-
late matter (PM) of 10 and 2.5 mm in size, carbon
monoxide, nitrogen oxide species, sulphur dioxide and
environmental tobacco smoke.
16e19 Finally, there is
a growing but limited body of evidence on the connec-
tion between genetics and asthma risk, as some antioxi-
dant and immune system gene polymorphisms (SNPs)
may increase susceptibility.
20e23
The diagnosis of asthma in population-based studies,
however, is challenging. Asthma is a clinical syndrome
that is associated with airways inﬂammation, airﬂow
limitation, bronchial hyper-responsiveness and symp-
toms of episodic wheeze and cough. Therefore, the need
to derive a practical deﬁnition of asthma for epidemio-
logical research has led to a focus on asthma symptoms.
To complement or validate the questionnaire-based
deﬁnitions of asthma, researchers have used measures of
airﬂow limitation
24 and bronchial hyper-responsiveness
as markers of asthma. However, both presence of airﬂow
limitation and bronchial hyper-responsiveness, even in
known patients with asthma, can be negative on the day
of testing. More recently, exhaled nitric oxide (eNO) has
been used as a marker of inﬂammation in asthma, but
results in epidemiological studies have been mixed
25
and eNO may better serve as a means to assess treatment
effectiveness or compliance. eNO may be elevated in
a variety of lung diseases, which are common in devel-
oping countries, and its utility as a screening tool in this
setting has not been evaluated.
Prompted by the paucity of published information on
the epidemiology of asthma in Peru, we established the
Peru Urban versus Rural Asthma Study to investigate
differences in prevalence, severity and risk factors for
asthma in two regions with disparate degrees of urbani-
sation. To investigate risk factors, we compared an urban
site where rates were likely to be high (Lima) with a rural
site where rates were likely to be low (Tumbes). Both
regions are coastal and at sea level. Whereas Lima is
highly urbanised, has high levels of outdoor air pollution
and low levels of household biomass burning, Tumbes
has low levels of outdoor air pollution and higher levels
of household biomass burning. In this manuscript, we
summarise the study design, implementation and stan-
dard operating procedures and provide quality control
data for important outcome and exposure variables.
METHODS
Study objectives
The primary objective of this study was to compare the
prevalence and severity of asthma in adolescence in an
urban and rural community in Peru. Secondary objec-
tives were to determine differences in: proportions of
atopic and non-atopic asthma, indoor air pollution
concentrations, contribution of genetic admixture to
asthma risk in these two populations; and the prevalence
of SNPs of asthma identiﬁed by genome-wide association
studies. An additional objective for data collected in Lima
was to determine the risk of asthma according to house-
hold distance from the major roadway in the community.
Study design
Our study was a cross-sectional study of asthma symp-
toms in 13e15-year-old adolescents in two regions in
Peru. We carried out the study in two phases (ﬁgure 1).
In the ﬁrst phase of the study, we obtained written
informed consent from parents and assent from chil-
dren. At this visit, we asked the parent and adolescent to
answer our survey. In the second phase, we revisited
children at their homes or schools to measure anthro-
pometry, to draw a blood sample, to perform an allergy
skin test, to measure eNO and to perform spirometry
before and after bronchodilator. We collected saliva
from participants who refused to give blood. In
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concentrations over 48 h.
Study sites
We show the location and altitude of both regions in
ﬁgure 2. Lima, the highly urbanised capital city of Peru,
is located on the central coast and has a population of
approximately 10 million. The site for our study in Lima
was Pampas de San Juan de Miraﬂores, a peri-urban
shanty-town located 25 km south of central Lima. This
community is described in detail elsewhere.
26 27 The
population mostly comprises highland immigrants.
Homes are made mostly of concrete or plywood, clus-
tered tightly with paved and unpaved roads separating
each city block. A four-lane highway divides the
community in half. Average ambient temperature in
Lima ranges between 178C and 308C year-round, and
relative humidity (RH) ranges between 55% and 80%.
Annual precipitation in Lima is 50 mm per year.
The second site for our study was the rural area of
Tumbes, located in the northern region of Peru
bordering with Ecuador. There are two main roads that
run through our study towns, which line the banks of the
Tumbes River. Average ambient temperature in Tumbes
ranges between 258C and 338C, RH ranges between 55%
and 80% and precipitation is much higher, with annual
rainfall up to 2200 mm per year.
Study population
Our target population was adolescents aged 13e15 years.
We identiﬁed participants from census data. The census
data in Lima was conducted originally in 1997 and
subsequently repeated in 2000, which was updated
several times thereafter. For these censuses, ﬁeldworkers
employed by A.B. PRISMA obtained the full name, age
and sex of each permanent household member. Census
data collection in Tumbes was completed in 2008,
immediately prior to the start of our study, by the
Proyecto de Eliminacio ´n de Cysticercosis (PEC). Maps
were made throughout the Tumbes region of Peru, and
again the full name, age and sex of each permanent
household member was obtained. For more information
on A.B. PRISMA and PEC, please see the ‘Study orga-
nisation’ section.
In Lima, we invited an age- and sex-random stratiﬁed
sample of subjects from the census to participate in our
study. In Tumbes, we invited all 13e15-year-old children
in the ﬁrst 23 villages along the Tumbes River to
participate. Adolescents were eligible to participate if
they were capable of understanding and performing
procedures, if their parents or guardians were capable of
providing written informed consent and they were
capable of providing assent; if they had no ocular,
abdominal or thoracic surgery in the last 3 months and if
they were not hospitalised for cardiac reasons in the
last 3 months. Children were ineligible to participate if
they had a chronic respiratory condition other than
asthma, such as cystic ﬁbrosis or chronic lung disease of
prematurity, if they were pregnant or if they had
pulmonary tuberculosis or were currently receiving
treatment for pulmonary tuberculosis. We recruited only
one adolescent per household.
Outcomes
The primary outcome for this study was self-report of
asthma symptoms. Current asthma symptoms were
deﬁned as wheezing or asthma medication use in the
previous year, while we deﬁned atopy as a positive test to
$1 skin test allergens. We consider a skin test as positive
if the sum of the vertical and horizontal dimensions of
the induration was $3 mm more than that of the
negative control or if the sum of the vertical and hori-
zontal dimensions of erythema was $5 mm larger than
that of the negative control. Meanwhile, we deﬁned
reversibility as a $12% increase in FEV1 after broncho-
dilator administration. We classiﬁed severity as per the
National Asthma Education Prevention Program
guidelines.
24 Other important outcomes include asthma
risk due to household distance from a highly trafﬁcked
avenue, differences in indoor air pollution, differences
Active enrolment
Lima:  stratified random sample
Tumbes:  complete sampling, 23 villages pp g , g
Phase 1
Consent (parent/guardian)
Assent (child)
Questionnaire
Phase 2
Anthropometry
Phlebotomy or saliva
Skin allergy test
Exhaled nitric  oxide
Spirometry pre- and post-salbutamol
Phase 3
Indoor PM measurement Indoor PM measurement
Lima:  100 (14.3%)
Tumbes:  70 (10%)
Figure 1 Procedure ﬂow chart. Flow chart shows course of
procedures, in order, for Peru Urban versus Rural Asthma
Study participants. As testing is ongoing, we opted not to
include numbers as they are subject to change. PM, particulate
matter.
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tions of SNPs associated with asthma between these two
populations.
Exposures
We asked about household characteristics and struc-
tures. We also asked about type of cooking fuels, lifetime
exposure to biomass fuels, tobacco exposure in the
house and trash burning. We measured indoor PM levels
via in-house monitoring, and we obtained outdoor levels
in Lima from the Peruvian governmental agency,
DIGESA (http://www.digesa.sld.pe). In Lima, an addi-
tional exposure was distance from the major four-lane
avenue that divides the community in half.
Sample size
The prevalence of asthma symptoms in the past
12 months in Peru was estimated at 20%e26% according
to the previous studies.
1 8 To estimate a prevalence of
current asthma symptoms of 20% with a precision of 3%
and 95% conﬁdence, we required 683 participants at
each site. Our initial assumption for loss to follow-up
between visits was approximately 5%. Therefore, we
aimed to enrol approximately 720 participants at each
site, which we achieved as noted below.
Study organisation
A.B. PRISMA in Lima, Peru and the Johns Hopkins
University in Baltimore, USA, provided administrative
oversight for the study. In Lima, the Pampas ofﬁce of
A.B. PRISMA provided operations and logistic support
for ﬁeldwork. In Tumbes, the PEC provided additional
operational and logistical support. There was a study
centre coordinator at each site (CLR and LMB) that was
responsible for protocol design and daily management
of questionnaire and physical testing teams. Each site
provided a data manager for database design, double-
data entry and database management. Additionally, at
Johns Hopkins were collaborating geneticists, environ-
mental scientists and epidemiologists with experience
in the design and conduct of population-based studies.
All investigators were involved in protocol design and
Figure 2 Map of Peru and study
sites. Lima, Peru (n¼725) and
Tumbes, Peru (n¼716) are
coastal regions and thus of low
altitude. Inset of Lima shows
Pampas de San Juan
neighbourhood divided into
quadrants by main thoroughfare
(vertical red line). Pampas de San
Juan is set on a large hill, with
base to the west and peak to the
east. Inset of Tumbes shows 23
rural study towns set along small
roadways on east and west
margins of the Tumbes River. City
of Tumbes at crossing of major
highway (thick black line) and river
(light blue).
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analyses.
Personnel, training and logistics
For each site, the local team was trained by the study
coordinators and a physician with expertise in spirom-
etry. Questionnaire interviewer training lasted
a minimum of 3 days in addition to ﬁeld piloting. Study
coordinators supervised interviewer performance in the
ﬁeld. Spirometry training lasted at least 2 weeks and
included observed pilot subjects outside the study
cohort.
In the ﬁrst phase of our study, we recruited partici-
pants into our study. We obtained written informed
consent from parents or guardians and assent from
adolescents and administered our survey at the time of
that encounter. This work was completed by nine trained
interviewers, four in Lima and ﬁve in Tumbes. In the
second phase of our study, we visited participants at their
homes or schools and measured anthropometry;
performed skin allergy testing, eNO and spirometry and
obtained a blood or saliva sample. In Lima, this was done
by two ﬁeld teams, each with one physician and one
trained health worker (nurse or nurse technician). In
Tumbes, all physical evaluations were done by a team of
one physician and at least one of the three health
workers (two nurse technicians and one lab technician).
In Tumbes, most tests were administered in schools,
while in Lima, most tests were done by home visitation.
All results were returned and explained to the partici-
pants, and we referred to a physician those whose results
suggested a diagnosis of asthma.
Questionnaire
We administered questionnaires (online supplement S1)
in the presence of the study participant and his or her
parent. The basis of the questionnaire was the validated
Spanish version of the ISAAC study.
28 We scrutinised this
translation with local health professionals at A.B.
PRISMA to ensure cultural appropriateness. In addition
to ISAAC questions, our questionnaire contained ques-
tions on asthma severity, food and medicine allergies,
household tobacco and combustible exposures, trash
burning, ventilation, household materials, household
animal exposure, time spent in home and family socio-
economic status. Assessment of asthma severity was based
on National Asthma Education and Prevention Program
guidelines.
24 We maintained a codebook to outline the
response to each question and facilitate quick data
reviews and cleaning.
Anthropometry
We measured participants in triplicate for height, weight
and blood pressure on the day of the appointment. We
measured height with a locally made stadiometer, weight
with a digital scale (Seca, Hamburg, Germany) and
blood pressure with an automated sleeve (OMRON
HEM712-C, Kyoto, Japan). We used the averages of the
three heights and weights as the ﬁnal values. Data sheets
for anthropometry, eNO and spirometry testing are
found in online supplement S2.
eNO testing
We used the NIOXMINO handheld portable eNO
monitor (Aerocrine New Providence, New Jersey, USA)
to measure eNO values in parts per billion. We
performed short daily and weekly calibrations as per
manufacturer’s instructions. Children performed a full
inhalation followed by a full steady exhalation at 50 ml/s.
All eNO tests were performed prior to spirometry to
avoid washout. Values were recorded manually.
Allergy skin testing
We performed allergy tests with the Multi-Test II system
(Lincoln Diagnostics, Decatur, Illinois, USA) and aller-
gens made by ALK-Abello (Round Rock, Texas, USA).
We used a total of 10 allergens: cockroach (Blattella
germanica), dust mite mix (Dermatophagoides farinae and D
pteronyssinus), cat hair, dog epithelium, mouse epithe-
lium and mixed molds (Alternaria, Cladosporium, mixed
Aspergillus and mixed Penicillium). As per manufacturer’s
instructions, we recorded vertical and horizontal
measurements of induration and erythema, alongside
0e2 scales of itchiness and pseudopodia. At each site,
a maximum two ﬁeldworkers, trained by the same
coordinator, read and recorded the reactions for
consistency (online supplement S3). We double-entered
measurements and used an algorithm based on the
manufacturer’s interpretation instructions to compare
dimensions of erythema and induration with negative
and positive controls (online supplement S5).
Spirometry
We performed spirometry with a portable, battery-oper-
ated, handheld spirometer (SpiroPro, Jaeger/Cardinal
Health, Hoechberg, Germany). SpiroPro uses disposable,
single-use factory-calibrated pneumotachometer tubes
(pneumotachs). We asked participants to withhold any
short-acting bronchodilators within 8 h and long-acting
bronchodilators for 24e48 h of testing unless clinically
necessary; however, we did not have instances where this
occurred. Our criteria were based on those European
Respi/European Respiratory Society American Thoracic
Society and European Respiratory Society (ATS/ERS)
29
which specify 4 h for short-acting bronchodilators and
12 h for long-acting bronchodilators. We revisited
participants who reported having a respiratory infection
in the last 2 weeks on a later date. Participants with heart
rate >140, systolic blood pressure >185 or diastolic blood
pressure >105 would not have been eligiblefor testing on
that day, although this did not occur. We obtained
information on smoking, alcohol and caffeine
consumption in the immediate period before testing,
although these were not considered exclusion criteria.
We asked each participant to perform a maximum of
eight prebronchodilator tests to attain three acceptable
error-free tests as per standard criteria.
30 We required
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end-expiratory plateau of 25 ml/s, to be without an
unsatisfactory start deﬁned by a back-extrapolation
volume that was either 5% or 150 ml of the forced vital
capacity (FVC) and to be free of cough or glottis closure
artefacts. Spirometry values were stored on the spirom-
eter, but we also recorded these values on a paper form.
The participant was then administered four doses of
salbutamol (100 mg/dose). Spirometry was repeated
15 min later. All manoeuvres were performed seated
upright with a nose clip. Field spirometry methods were
pilot tested at each site at least 50 times by each spiro-
metrist prior to ﬁeld implementation.
To ensure reproducibility, the two highest values of
prebronchodilator FEV1 and of prebronchodilator FVC
could not have intra-test variability >150 ml.
30 The same
applied for postbronchodilator FEV1 and FVC. In addi-
tion, the highest single postbronchodilator FEV1 and
FVC values could not be 150 ml less than the highest
prebronchodilator FEV1 and FVC values, respectively.
Spirometrists immediately reviewed all curves for quality
of inhalation and expiration curve shape. Participants
who did not meet these criteria were asked to repeat
spirometry testing on a different day, with up to three
opportunities. Additional grading according to slightly
modiﬁed standard criteria
31 were performed at the end
of the study. Spirometry data were sent electronically to
Johns Hopkins University (WC) for regular assessment
and feedback. We held regular conferences (CLR, LMB
and WC) to review ﬂow curves and provide feedback.
Blood draw and processing
All blood was drawn by standard phlebotomy techniques
into non-heparinised 10-ml Vacutainer tubes (Becton-
Dickinson, Franklin Lakes, New Jersey, USA). Blood was
drawn either prior to allergy testing or more than 24 h
following this test to not inﬂuence IgE levels. Small
amounts of blood were immediately gathered into
heparinised capillary tubes for haematocrit processing.
Blood in Vacutainer tubes was refrigerated at 48C for
<48 h prior to separation into coagulate and serum.
After separation, all samples were subsequently stored at
 208C. DNA was later extracted from the coagulate
using a salt-wasting (ie, phenolechloroform extraction)
protocol in our laboratory at UPCH in Lima. Serum and
DNA samples from each patient were sent overnight to
the USA for processing and storage, while a back-up copy
of each remains stored at  208C in Lima.
We will analyse blood sera for total human serum IgE
using a United States Food and Drug Administration
cleared ﬂuorescent enzyme immunoassay (Immu-
noCAP250; Phadia, Kalamazoo, Michigan, USA). The
assay involves binding IgE in the test specimen to an anti-
IgE, which has been immobilised on a solid-phase
matrix. Following removal of unbound proteins with
a buffer wash, bound IgE is quantitatively detected with
an enzyme-labelled anti-human IgE reagent. The assay is
calibrated using a standard curve that has been cross-
validated to known quantities of total IgE in the WHO
75/502 IgE International Reference Preparation. Results
are reported in kilo IU of IgE per litre (kU/l). The
serum samples will also be processed for vitamin D levels
using the LIAISON 25 OH vitamin D total assay
(DiaSorin Inc, Stillwater, Minnesota, USA). The assay is
a direct competitive chemiluminescence immunoassay
for determination of metabolised 25-hydroxyvitamin D
quantities in serum. The process involves disassociation
of 25-OH vitamin D from its serum binding protein and
subsequent binding to a speciﬁc antibody on a solid-
phase matrix. Following removal of unbound proteins
with a buffer wash, antibody-bound 25-OH vitamin D
levels are detected by initiating a ﬂash chemilumines-
cent reaction and measurement of light signals. The
LIAISON assay is calibrated using a predeﬁned master
curve that has been adjusted according to instrument-
speciﬁc calibration. Results are reported in units of
nanograms of 25-OH vitamin D per millilitre (ng/ml).
Saliva DNA collection
In the event blood draw was refused, we collected saliva.
The patient was instructed to spit 2 ml of sputum-free
saliva into the Oragene DNA Self Collection Kit (DNA
Genotek, Ontario, Canada) and stored at room temper-
ature. DNA was then extracted as per manufacturer’s
instructions.
Genetic analysis
We will perform genetic analysis of several well-repli-
cated genes associated with asthma and total IgE in other
populations.
32 33 Our main interest is to characterise the
frequency of variants of those genes among patients with
and without asthma across the two study sites. Geno-
typing of SNPs for ADAM33, CD14, GSTM1, GSTP1, IL4,
IL13, IL1RL1, TSLP and IL33 (table 1) will be
performed using the custom-designed Illumina (San
Diego, California, USA) oligonucleotide pool assay for
the BeadXpress Reader System, which combines the
GoldenGate Assay with VeraCode Bead technology
(http://www.illumina.com).
We will also genotype for vitamin D receptor poly-
morphisms GC, VDR, CYP2B1, CYP2R1 and CYP24A1
using the same approach (table 1). We will explore
population structure in these two groups as the basis for
future admixture mapping studies. To evaluate genetic
structure of the ethnic groups from the three ancestral
populations in the HAPMAP (http://www.hapmap.org),
we will genotype an additional 384 SNPs identiﬁed as
ancestry informative markers selected for maximal
difference between Native American, European and
African populations.
Indoor PM concentration
In Lima, we allocated all participating households into
11 geographic zones based on 300-m increments from
the main avenue. We randomly selected a geographic
zone-stratiﬁed sample of 100 households for monitoring,
approximately nine from each zone. In Tumbes, we
randomly selected households proportional to the total
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households. Passive PM concentrations, collected only
on weekdays, were measured over 48 h using a portable
nephelometer (pDR-1000; Thermo Scientiﬁc, Franklin,
Massachusetts, USA). Empirical evidence suggests that
the pDR-1000 detects particles in the size range of
0.3e2 mm more efﬁciently than those of 2e10 mm.
34e36
Quintana et al
35 reported a high degree of correlation
between the PM determined by the pDR-1000 and PM2.5
measurements. Thus, PM measured with the pDR-1000 is
an accurate approximation for PM2.5.
We collected RH and temperature data concurrently
using the HOBO Data Logger (Onset Computer
Table 1 Single nucleotide polymorphisms of candidate
genes associated with asthma
Gene Loci Polymorphism
ADAM33 rs570269 C/G
rs677044 A/G
rs11905870 C/T
rs2787095 C/G
rs12479696 A/T
rs6115987 C/T
rs3918395 A/C
rs2853210 C/T
rs487377 C/T
rs554743 C/T
rs7354032 A/G
rs511898 C/T
rs598418 A/G
CD14 rs3776138 C/G
rs2569190 A/G
rs5744456 A/T
GSTM1 rs2239892 A/G
GSTP1 rs8191439 A/C
rs1138272 C/T
rs1695 A/G
rs749174 A/G
rs1871042 C/T
rs4147581 C/G
IL4 rs2243258 C/T
rs2243283 C/G
rs2243261 G/T
rs2243252 C/T
rs2243276 C/T
rs2070874 C/T
rs2243266 A/G
rs734244 C/T
rs2243267 C/G
rs2243288 A/G
rs2227282 C/G
rs2243263 C/G
rs2243268 A/C
rs2243270 A/G
rs2243274 A/G
rs2243279 A/G
rs2243282 A/C
rs2243290 A/C
IL13 rs2069744 C/T
rs20541 A/G
rs2069745 C/G
rs1295687 C/T
rs1295686 C/T
rs1295685 A/G
rs848 A/C
Continued
Table 1 Continued
Gene Loci Polymorphism
ILR1 rs10197862 A/G
rs10204137 A/G
rs10206753 C/T
rs11123918 C/T
rs12712142 A/C
rs12905 A/G
rs12999517 C/T
rs13431828 C/T
rs1921622 A/G
rs2160203 A/G
rs3771175 A/T
rs4988958 C/T
TSLP rs2289276 C/T
rs10062929 A/C
rs11466741 C/T
rs11466744 G/T
rs11466749 A/G
rs11466750 A/G
rs6864123 A/G
IL-33 rs4742170 C/T
rs10975514 A/G
rs7037276 C/T
rs10975516 A/G
rs1317230 A/C
rs1330383 G/T
rs10975519 C/T
rs10975520 C/G
rs1412420 A/G
rs7047921 A/G
rs7019575 A/T
rs1332290 G/T
rs16924241 C/G
rs1048274 A/G
rs16924243 C/T
rs12000491 C/T
rs7036053 C/T
GC rs115563 T/C
rs22822679 A/C
rs12512631 T/C
VDR rs2228510 G/A
rs10783219 A/T
rs71339166 C/G
rs4516035 T/C
CYP2B1 rs703842 T/C
rs4646536 T/C
rs10877012 G/T
CYP2R1 rs10741657 G/A
rs10766197 G/A
CYP24A1 rs2244719 T/C
rs2296241 A/G
rs2426496 T/G
rs17219315 A/G
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Asthma in Peru by degree of urbanisationCorporation, Bourne, Massachusetts, USA). We cali-
brated all pDR-1000s to a zero measurement before each
trial and then placed them between 1.5 and 2.0 m in
height in the main living room (ﬁgure 3). We adjusted all
PM measurements to consider effects of high RH using
the following correction factor CF¼1 + 0.253RH
2/
(1 RH). The crude PM value was then divided by the CF
to provide an adjusted PM measurement.
37 We recorded
dimensions of the room in which the machine was placed
in all households (online supplement S4). We also
recorded the location and size of all windows and doors,
as well as whether windows and doors were opened
or closed. DIGESA measured outdoor PM of 10 and
2.5 mm in a high-trafﬁc area in the southern region of
Lima approximately 1.5e2.0 km from our study
community.
Geographic information systems mapping
We measured global positioning system coordinates for
each participating household in Lima. We calculated the
distance from each home to the main avenue (Avenida
Miguel Iglesias) using the program ArcGis 9.3 (ESRI
Corporation, Redlands, California, USA).
Data management
All questionnaire data were double-entered at each site
via Microsoft ACCESS (Microsoft Corp. Redmond,
Washington, USA), and these two data sets were cross-
compared for validity and errors. Spirometry data were
collected electronically and on paper forms. Data from
the spirometers were downloaded daily or every other
day into a computer database. An extensive combined
data set was created using the data extracted from
SpiroPro and cross-referenced with data double-entered
on paper forms. Other testing data, such as anthro-
pometry, allergy testing, eNO and other environmental
data, were written on the paper forms and also double-
data entered. PM concentration and RH data were
collected electronically. We developed an ACCESS
program to merge the PM and RH data using the date
and time stamp and calculated the adjusted PM as
described above. Detailed data codebooks were created
for each data set to ensure consistency between the two
sites and facilitate database management.
Speciﬁc aims and statistical considerations
The speciﬁc aims of this study were as follows: (1)
determine differences in prevalence and risk factors of
asthma between peri-urban and rural adolescents in
Peru, (2) determine the relationship of total serum IgE
to asthma and lung function in peri-urban and rural
adolescents in Peru, (3) determine the effects of serum
vitamin D concentrations and vitamin D receptor poly-
morphisms on the prevalence of asthma in peri-urban
and rural adolescents in Peru, (4) determine the effect
of genetic differences by gene ancestry mapping and
single nucleotide polymorphisms on the prevalence of
asthma between peri-urban and rural adolescents in
Peru, (5) determine genetic differences by gene ancestry
mapping and single nucleotide polymorphisms that may
be associated with lung function in peri-urban and rural
adolescents in Peru. In this manuscript, we summarise
quality control data with simple means and percentages.
Statistical methods used to test differences in the prev-
alence and risk factors of asthma between Lima and
Tumbes were presented in detail in two previous publi-
cations.
38 39 Subsequent publications will also present
detailed statistical methods.
Ethical considerations
We obtained approval from the Ethics Committees of
A.B. PRISMA in Lima, Peru, and Johns Hopkins
University, Bloomberg School of Public Health, in
Baltimore, Maryland. Since all participants were younger
than 18 years, written informed consent was obtained
from parents or guardians and assent was obtained
from the participant. All subjects were offered fruit or
crackers and a juice box upon completion of the
examination. Test results were delivered at a subsequent
visit, at which time a ﬁeldworker or team physician
explained the results to the parents. Those with asthma
symptoms or other medical concerns were offered
a consultation with our study physicians and referred to
a local physician. Subjects with anaemia were given
30 days of iron supplements and recommended to
follow-up with their physicians. All data ﬁles and sensitive
information were kept on password-protected devices
that were only accessible to study coordinators for
conﬁdentiality.
RESULTS
Of the 1851 potential participants listed on our censuses
and approached across both sites, a total of 1441
adolescents were recruited to participate in the study,
725 in Lima and 716 in Tumbes. In Lima, 321 (30.4%)
refused participation or were unable to be contacted,
Figure 3 Particulate matter measurement device in place.
pDR-1000 in place in study household, accompanied by HOBO
Data Logger and protected by open cage for air ﬂow.
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Asthma in Peru by degree of urbanisationwhile 10 (0.9%) were ineligible, generally because their
ages fell out of our study age range. In Tumbes, 67
(8.4%) refused participation or were unable to be
contacted, while 12 (1.5%) were ineligible for similar
reasons. Of those not enrolled from census, there were
no signiﬁcant differences in distribution by age or sex
(data not reported).
Participants were 52% boys overall, with 49% boys in
Lima and 54% boys in Tumbes. At the start of the
project, ages were evenly distributed in both sexes
(ﬁgure 4). At recruitment, 20% were 13 years old, 34%
were 14 years old, 34% were 15 years old and 12% of
participants had just turned 16 years. Of the 1441
participants, physical tests were fully completed on
80.4% (1159/1441): 75.2% (545/725) in Lima and
85.8% (614/716) in Tumbes. In addition, at least one
test was completed on 91.7% (1321/1441): 90.0% in
Lima (653/725) and 93.2% in Tumbes (668/716).
Questionnaire
All participants completed the questionnaire in full in
the presence of at least one parent or guardian. There
were few missing data. In reviewing 35 random surveys
from each site, we found that 0.1% and <0.1% of survey
ﬁelds were ﬁlled out incorrectly in Lima and Tumbes,
respectively. We also found rates of 0.02% and 0.1% for
data entry errors in Lima and Tumbes, respectively.
These two sets of values represent errors following daily
review of new questionnaires and quality checks of
double data entry.
Spirometry
In Lima, 86% (625/725) of recruited participants
completed spirometry according to our prespeciﬁed
criteria, while in Tumbes, that value was 90% (646/716).
Overall, this represents 88% of all recruited children
(1271/1441). Of all children who were approached for
Figure 4 Age and sex
distributions by site. Study
demographic distribution shows
few changes in sex and age
distributions from all individuals in
both sites (top two panels), all
included in census (middle two
panels) and all recruited (bottom
two panels). Thus, sampling and
recruitment shows no bias. Also,
very few differences in distribution
are seen between sites,
comparing left and right. The x-
axis refers to per cent contribution
of each population to the total
population. The y-axis refers to
age of participants. White bars
refer to boys and black bars refer
to girls.
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Asthma in Peru by degree of urbanisationspirometry at all, 97.2% (1271/1308) successfully
completed the testing within three visits: 96.7% (625/
646) in Lima and 97.6% (646/662) in Tumbes.
The overall percentage of spirometry tests that
resulted in both acceptable and reproducible prebron-
chodilator and postbronchodilator tests was 77%. Our
acceptability criteria were based directly on the ATS/ERS
and were as follows: expiration $6.0 s; back-extrapola-
tion volume <5.0% of the FVC or <150 ml, whichever is
larger; the end-expiratory plateau <25 ml/s and no
evidence of cough, glottis closure or leaks upon curve
review.
30 Reproducibility was determined per previously
described guidelines.
Using these criteria, 85.5% of all prebronchodilator
spirometry appointments were acceptable and repro-
ducible and 91.7% of postbronchodilator efforts were
acceptable (79.8% of all appointments). When applying
prebronchodilator to postbronchodilator reproducibility
criteria, 76.8% of all appointments were entirely
acceptable and reproducible.
Concerned that the ATS/ERS reproducibility criteria
were too stringent, we decided to analyse reproducibility
as per a modiﬁed version of spirometry criteria
published by Ferguson et al
31 In brief, the criteria are as
follows: Grade 1 ($3 curves acceptable per the ATS/ERS
criteria with the best two repeatable within 150 ml for
FEV1 or FVC); Grade 2 ($2 acceptable curves, repeat-
able within 150 ml for FEV1 or FVC); Grade 3 ($2
acceptable curves, repeatable within 250 ml FEV1 or
FVC); Grade 4 (one acceptable curve); and, Grade 5 (no
acceptable curves). We only considered Grades 1e3t o
be acceptable and reproducible. Using these criteria,
97.4% of all prebronchodilator spirometry appoint-
ments were acceptable and reproducible and 99.2% of
postbronchodilator efforts were acceptable (86.4% of all
appointments). Thus, employing Ferguson criteria
would have included a slightly greater number of tests in
our study and reduced the number of return visits.
Allergy skin testing
We placed 1244 skin allergy tests (Lima¼614,
Tumbes¼630). In Lima, 96.9% of positive control tests
resulted in positive reactions, while 85.8% of negative
controls resulted in negative reactions. In Tumbes,
a similar 95.1% of positive control tests were interpreted
as positive, while 98.7% of negative controls showed up
as negative. This disparity between negative control
testing in Lima and Tumbes may reﬂect increased
baseline skin irritability in Lima, given higher observed
rates of atopy in Lima.
Prevalence of asthma
We found current asthma prevalence to be 12% (84/
725) in Lima and 3% (22/716) in Tumbes. Current
asthma was deﬁned as wheeze symptoms and/or use of
asthma medication in the past 12 months. In Lima, 52%
(44/84) of patients with asthma presented with mild
intermittent asthma, and in Tumbes, 55% (12/22) of
patients with asthma were classiﬁed as mild intermittent,
as shown in table 2. Only 5% (4/84) of patients with
asthma in Lima presented with severe persistent symp-
toms compared with 14% (3/22) in Tumbes.
Environmental testing
We achieved our goal of 100 household 48-h PM
measurements in Lima and 70 in Tumbes. Outdoor
PM10 levels recorded by the Peruvian agency DIGESA
during the study, calendar year 2009, were 78.6 mg/m
3
and showed highest levels during the cooler months of
May, June and July. Outdoor PM2.5 levels were much
lower at 40.2 mg/m
3 and did not show the same peak
during the cooler months. While no international
outdoor PM2.5 concentration standard exists, these are
2.7-fold higher than US Environmental Protection
Agency standard.
DNA collection
Overall, 1326/1441 (92%) of study participants agreed
to give a blood sample. We successfully collected blood
from 568 participants in Lima (78%) and 578 partici-
pants (81%) in Tumbes. We also collected saliva samples
in 65 participants in Lima (9%) and 83 participants in
Tumbes (12%) who did not perform or refused blood
draw. Overall amounts of DNA obtained from blood
extractions have been 25.6 mg, with a 260/280 ratio of
1.86. Overall average amounts of DNA extracted from
saliva samples have been slightly higher at 28.0 mg, with
a comparable 260/280 ratio of 1.89 (table 3).
DISCUSSION
Our study portends to offer a comprehensive under-
standing of asthma in two regions of Peru. It will provide
prevalence, exposure and risk factor data and highlight
differences in asthma between rural and urban areas. We
employed questionnaires on asthma symptoms, spirom-
etry with reversibility, skin allergy testing, eNO testing
Table 2 Asthma severity by site
Asthma severity
classiﬁcation, N (%)
Lima
(N[84)
Tumbes
(N[22)
Mild intermittent 44 (52.4) 12 (54.5)
Mild persistent 18 (21.4) 4 (18.2)
Moderate persistent 18 (21.4) 3 (13.6)
Severe persistent 4 (4.8) 3 (13.6)
Table 3 Quality and quantity of DNA extraction
Lima Tumbes Overall
Blood, mean (SD) n¼568 n¼578 n¼1146
Mass (mg) 13.6 (6.7) 36.3 (29.3) 25.6 (24.6)
260/280 1.86 (0.04) 1.87 (0.14) 1.86 (0.11)
Saliva, mean (SD) n¼65 n¼83 n¼148
Mass (mg) 36.2 (32.9) 23.1 (17.1) 28.0 (24.9)
260/280 1.88 (0.08) 1.89 (0.07) 1.89 (0.08)
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we will not only address our initial study question as to
the disparity in asthma rates across the two regions but
we hope to contribute information regarding differences
between genetics and environmental exposures and to
explore interactions between the two. There is potential
for a longitudinal cohort built into the Peru Urban
versus Rural Asthma Study, as nearly all families granted
permission for future contact.
Our study implemented large-scale organisation and
quality control methods across separate study sites.
Available census data at both study sites were an invalu-
able tool for our work. Standardisation and regular
sharing of information across sites proved a successful
method to ensure seamless data collection and facilitate
ease of comparing data. All ﬁeldworkers were trained
under the supervision of the same project administra-
tors, and ﬁeld visits by all administrators at each site
over the course of the study helped to maintain
consistency.
While we have successfully collected a range of data on
both populations, this did not come without difﬁculties
and shortcomings. The most difﬁcult task was to ﬁnd
participants in by home visitation in the second phase of
our study, especially in Lima. In Tumbes, most partici-
pants studied at the school within their own or neigh-
bouring village and were thus accessible for testing.
However, it was not possible to apply the same strategy in
Lima, given the higher number of schools attended by
the study children and the greater distances of these
schools from the neighbourhood. In addition, because
of the community-based nature of our study, which
included home visitations in Lima, we found that it was
not logistically feasible to perform exercise challenge
testing as an additional marker of asthma. Transporting
a stationary bike and necessary accessories would have
been very difﬁcult in Lima, where we visited children in
their homes and could not work in schools. Adminis-
tering running exercise tests would have also been quite
difﬁcult in the urban environment of Pampas de San
Juan de Miraﬂores, given that many of the streets in this
community are on an incline.
It was more common in Tumbes for at least one parent
to be at home at any point during the day. Therefore,
coordinating second appointments in Lima after initial
recruitment was difﬁcult in many cases and impossible in
others. We attempted to optimise our time by
contracting transportation workers in Lima to work with
the team, decreasing travel time between appointments,
but we were still limited by participant availability. In
future population-based work that includes physical
testing in our community and in similar studies, we
recommend that all questionnaires and testing be
performed during these home visits on the same day of
enrolment to minimise loss to follow-up. Finally, we
required several return visits to meet the ATS/ERS
spirometry reproducibility criteria. Had we used less
stringent standards, namely the Ferguson criteria,
31 we
would have been able to include a slightly greater
number of tests while saving time by not having to return
to participants whose ﬁrst appointments did not meet
the ATS/ERS criteria.
Nonetheless, our study shows that we can collect
extensive high-quality data by home visitation in
a resource-poor setting, and therefore, this type and
quality of data may be collected in other, though not
necessarily all, resource-poor settings as well. To this
point, based on the data collected by the methods
described in this paper, we have published two initial
manuscripts.
38 39 Because of the quality of data that we
describe, we can be conﬁdent in the quality and ﬁdelity
of our ﬁndings in these separate analyses. We are
currently working on side projects that more closely
target identiﬁed patients with asthma, assess quality of
life as a result of asthma or even elucidate the value of
eNO for the identiﬁcation of new-onset asthma in
a population-based study.
40 Most importantly, we hope to
combine the asthma symptoms and environmental
results of our study with extensive genetic analyses via
candidate gene and genome-wide association studies.
Once the results are collected for our study and other
projects, we will be able to design targeted interventions
to at-risk children via health presentations in schools,
meetings with community leaders or even provide the
data to the Peruvian government to begin to affect
change in pollution regulations.
CONCLUSIONS
In conclusion, we successfully conducted a cross-
sectional asthma prevalence study in two diverse settings
in Peru. We were able to show that high-quality data on
asthma symptoms, measures of airﬂow obstruction and
markers of airway inﬂammation can be successfully
collected by home visitation in a resource-poor setting.
From preliminary data, we are conﬁdent that this testing
will reliably demonstrate differences in asthma rates as
well as the characteristics of patients with asthma
between the two sites. While we hope to better describe
asthma in the context of a developing country, we also
seek to better characterise the various factors contrib-
uting to a burdensome health issue that is growing
internationally.
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